TP53 and cancer: Based on high fold regulation, the top activated pathways were proteoglycans in cancer, the Notch signaling pathway, the p53 signaling pathway, endocrine resistance, T helper (Th)1 and Th2 cell differentiation, hematopoietic cell lineage, homologous combinations, and platinum drug resistance (Figure 5C).